EP PerMed Newsletter 19 | 04 May 2026

Dear subscribers,

welcome to the latest edition of the EP PerMed Newsletter.

In this issue, we are pleased to share updates on upcoming EP PerMed activities, including the Implementation School on Personalised Medicine in Vilnius, our 3rd Round Table in Copenhagen, and a save-the-date for the joint EP PerMed and ICPerMed conference in Berlin in 2027.

Beyond EP PerMed, this newsletter features selected news and events from the wider personalised medicine community, including new calls, reports, courses and conferences across Europe.

The EP PerMed Consortium

EP PerMed News

04 May 2026

EP PerMed 3rd Round Table: Challenges and Best Practices in the Implementation of Personalised Medicine Approaches in Nordic Countries – Industry View

EP PerMed is organising the 3rd edition of its Round Table series on 18 May 2026 in Copenhagen, Denmark. The event aims to collect concrete insights from industry experts on the opportunities and challenges of personalised medicine (PM), including real-life examples of problems encountered and effective solutions. It also aims to understand how successful approaches can be transferred from academia, scaled across countries and implemented effectively.

04 May 2026

Implementation School on Personalised Medicine – A Sex- and Gender-Sensitive Approach

The EP PerMed Implementation School on Personalised Medicine will take place from 27 to 30 October 2026 in Vilnius, Lithuania. The event will focus on integrating sex and gender perspectives into clinical practice, research, and health systems. This interactive programme will bring together clinicians, researchers, public health professionals and policymakers to explore how gender-sensitive approaches can be translated into real-world practice.

04 May 2026

Save-the-Date! Joint EP PerMed & ICPerMed Conference in Berlin

EP PerMed and ICPerMed will jointly organise a conference in Berlin, Germany, in the period of 27-29 April 2027. The event will focus on collaborations to accelerate personalised medicine innovations and solutions into healthcare. The event is currently planned as a two-day conference, with an additional welcome event for participants arriving the day before. More information on the event will be available soon.

27 April 2026

New Podcast Episode: Valentina’s Lymphoma Story and personalised CAR T-cell Therapy

For Valentina, changing homes and continents was meant to mark a new beginning. However, the diagnosis of lymphoma came just as everything seemed ready. Within hours, her life was turned upside down, culminating in an experimental treatment at the time: CAR T-cell therapy.

21 April 2026

General Assembly Meeting

EP PerMed held its General Assembly meeting on 21 and 22 April in Brussels. As the partnership’s formal decision-making body, the General Assembly brings together all partner organisations to discuss and decide on EP PerMed’s strategic direction, key priorities, supported actions, and the allocation of budget for implementing its activities.

During the meeting, colleagues from across the EP PerMed work packages presented selected activities and achievements, including example projects from the Fast Track Call and the first EP PerMed Hackathon in Ostend, Belgium. Partners also discussed the partnership’s financial reporting and the monitoring of key performance indicators.

Looking ahead, the General Assembly also discussed several important upcoming activities, including the next EP PerMed Summer School and the soon-to-be-launched EP PerMed Stakeholder Forum.

Other PM-related News

27 April 2026

ICPerMed Webibar - The Canadian Precision Health Initiative (CPHI)

In the frame of the ICPerMed Strategic Working Group on Internationalisation, a webinar will be organised on 28 May 2026 from 15:00 to 16:30 CEST. Dr Étienne Richer, Director of Genomics Programs at Genome Canada, will present the Canadian Precision Health Initiative (CPHI).

27 April 2026

TRANSCAN JTC2026 – Translational Research on Cancer Metabolism

The TRANSCAN project has pre-announced its JTC2026, focusing on ‘Translational Research on Cancer Metabolism: Multidisciplinary Approaches for Diagnosis and Treatment’. The call will launch on 20 May 2026. Pre-proposals must be submitted by 21 July 2026.

24 April 2026

genomDE Symposium 2026 to Spotlight Genomic Medicine in Germany

The 5th genomDE Symposium will take place on 28–29 September 2026 at the Bundeskunsthalle in Bonn. Hosted by BfArM, the event will bring together experts from genomic medicine, research, healthcare and policy to discuss the future of genomic medicine in Germany.

24 April 2026

WHO Report on AI in Health Care across EU Member States

WHO/Europe has published a new report assessing the use of artificial intelligence (AI) in health care across the 27 European Union Member States. The report shows that AI is becoming increasingly embedded in health systems, with all EU countries recognising its potential to improve patient care.

24 April 2026

PRECISEU Call: Advancing Interregional Innovation in Personalised Medicine

The PRECISEU project has published a call to support innovative interregional projects in personalised medicine under the Regional Innovation Valleys framework. The call will empower SMEs, startups and innovation actors to develop and scale solutions in ATMPs and health data, strengthening regional ecosystems and accelerating the uptake of high-impact, patient-centred innovations across Europe.

13 April 2026

WHO Online Course: Good Practices for Clinical Trial Design and Implementation

The World Health Organization (WHO) launches a free, online, self-paced online course on ‘Good Practices for Clinical Trial Design and Implementation’. Designed to provide a comprehensive understanding of the factors that contribute to trial quality, the course covers five key scientific and ethical principles for designing and conducting high-quality clinical trials.

13 April 2026

PROPHET project presents SRIA and Roadmap on Personalised Prevention

On 26-27 March, the Coordination and Support Action (CSA) PROPHET presented the results of its work: a Strategic Research and Innovation Agenda (SRIA) and a Roadmap for Personalised Prevention. During the PROPHET event, Monika Frenzel (ANR and EP PerMed WP2 lead) has presented EP PerMed and its activities related to personalised prevention, e.g. via research calls, communication or training activities. Personalised prevention is also part of the Strategic Research and Innovation Agenda for Personalised Medicine (SRIA for PM, 2023).

The CSA PROPHET is the last project of the so called ICPerMed Family, a set of projects financially supported by the European Union under the Horizon 2020 framework programme in the field of personalised medicine and connected to or in support of the International Consortium for Personalised Medicine (ICPerMed).

See all news